Response to Letter to the Editor regarding “Melanotan II injection resulting in systemic toxicity and rhabdomyolysis” in Clinical Toxicology 2012; 50(10):1169–73.

Michael E. NelsonDepartment of Emergency Medicine, Stroger Hospital of Cook County, Illinois Poison Control Center, Chicago, IL, USACorrespondence[email protected]

Sean M. BryantDepartment of Emergency Medicine, Stroger Hospital of Cook County, Illinois Poison Control Center, Chicago, IL, USA

Steven E. AksDepartment of Emergency Medicine, Stroger Hospital of Cook County, Illinois Poison Control Center, Chicago, IL, USA

References

Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, Hadley ME. Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci 1996;58:1777–1784.
PubMed Web of Science ®Google Scholar
Hadley ME. Discovery that a melanocortin regulates sexual functions in male and female humans. Peptides 2005;26:1687–1689.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Response to Letter to the Editor regarding “Melanotan II injection resulting in systemic toxicity and rhabdomyolysis” in Clinical Toxicology 2012; 50(10):1169–73.

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Response to Letter to the Editor regarding “Melanotan II injection resulting in systemic toxicity and rhabdomyolysis” in Clinical Toxicology 2012; 50(10):1169–73.

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date